Amsacrine (AMSA)--a clinical review.
D000328:Adult; D000609:Aminoacridines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000677:Amsacrine; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001424:Bacterial Infections / Q000139:chemically induced; D001853:Bone Marrow / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004064:Digestive System / Q000187:drug effects; D004304:Dosage Forms; D004341:Drug Evaluation; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D005833:Genital Neoplasms, Female / Q000188:drug therapy; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000188:drug therapy; D008099:Liver / Q000187:drug effects; D008113:Liver Neoplasms / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D009422:Nervous System Diseases / Q000139:chemically induced
D000609:Aminoacridines; D000970:Antineoplastic Agents; D004304:Dosage Forms; D000677:Amsacrine